Staidson (Beijing) Biopharmaceuticals Co., Ltd.(300204.SZ)

Search by Type

Report DataBase News

Search by Company

Code Company name

Category

Home>300204.SZ

Remember Me Next Time

Staidson (Beijing) Biopharmaceuticals Co., Ltd.(300204.SZ)

Profile

Registered Capital:

66.70(RMB MLN)

Employees：

220

Email：

securities@staidson.com

WebSite：

http://www.staidson.com

Tel：

010-67875255

Fax：

010-67875255

Reports

Databasemore..

Operating Income and Proportion of Staidson (beijing) Biopharmaceuticals (By Product), 2008-20102011-8-15
Operating Income and Proportion of Staidson (beijing) Biopharmaceuticals (By Business), 2008-20102011-8-15

Revenue Breakdown (million RMB)

Industry	2010	2009	2008
Technology transfer income	1.60	**	**
Technical service income	0.50	**	**
Total	128.21	**	**

Products	2011H1	2010	2009	2008
Polyethylene glycol	**	**	**	**
Aspirin (50ml)	**	**	**	**
Nabumetone	**	**	**	**
Gelieqite	**	**	**	**
Injection of mouse nerve growth factor	**	**	**	**
Total	**	**	**	**
Technology transfer income	**	**	**	**
Technical service income	**	**	**	**

Introduction from Company WebSite

Staidson (Beijing) Biopharmaceuticals Co., Ltd. engages in the research, development, production, and sale of biopharmaceutical products in China. The company’s products include Su peptide health injection for the treatment of optic nerve injury; Shu Taiqing, a polyethylene glycol electrolyte powder; Gliclazide tablets and capsules; Nabumetone; and Aspirin. Staidson (Beijing) Biopharmaceuticals Co., Ltd. was founded in 2002 and is based in Beijing, China.